Migraine Epidemiology Forecast to 2030 – Focus on US, France, Germany, Italy, Spain, UK, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Migraine – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.

This report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for migraine in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

The report includes a 10-year epidemiology forecast for the 12-month total prevalent cases and 12-month diagnosed prevalent cases of migraine. The 12-month total prevalent cases and 12-month diagnosed prevalent cases of migraine are segmented by age (18 years and older), sex, subtype (migraine with aura and migraine without aura).

The report also includes the 12-month total and 12-month diagnosed prevalent cases of migraine further segmented by migraine frequency into episodic migraine and chronic migraine for both sexes and ages 18 years and older.

The following data describes epidemiology of migraine. In the 7MM, the publisher epidemiologists forecast an increase in the 12-month total prevalent cases of migraine from 72,739,456 cases in 2020 to 73,708,346 cases in 2030, at an AGR of 0.13% over the forecast period.

Women accounted for more 12-month total prevalent cases of migraine than men in the 7MM and it predominantly affects younger adults. These findings are in line with the publisher estimates and these trends are reflected in the publisher’s forecast for the 12-month total prevalent cases for the 7MM.

Scope

• The Migraine Epidemiology Report provides an overview of the risk factors and global trends of Migraine in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report includes a 10-year epidemiological forecast for the 12-month total prevalent cases and 12-month diagnosed prevalent cases of migraine segmented by sex and age (ages ?18 years). The 12-month total prevalent cases and 12-month diagnosed prevalent cases of migraine are further segmented by subtype (migraine with aura and migraine without aura). The report also includes the 12-month total and 12-month diagnosed prevalent cases of migraine further segmented by migraine frequency into episodic migraine and chronic migraine for both sexes and ages 18 years and older.
• The migraine epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Key Topics Covered:

1 Migraine: Executive Summary

1.1 Catalyst

1.2 Related Reports

1.3 Upcoming Reports

2 Epidemiology

2.1 Disease Background

2.2 Risk Factors and Comorbidities

2.3 Global and Historical Trends

2.4 7MM Forecast Methodology

2.4.1 Sources

2.4.2 Forecast Assumptions and Methods

2.4.3 Forecast Assumptions and Methods: 12-Month Total Prevalent Cases of Migraine

2.4.4 Forecast Assumptions and Methods: 12-Month Total Prevalent Cases of Migraine by Frequency

2.4.5 12-Month Total Prevalent Cases of Migraine by Type

2.4.6 12-Month Diagnosed Prevalent Cases of Migraine

2.5 Epidemiological Forecast for Migraine (2020-2030)

2.5.1 12-Month Total Prevalent Cases of Migraine

2.5.2 Age-Specific 12-Month Total Prevalent Cases of Migraine

2.5.3 Sex-Specific 12-Month Total Prevalent Cases of Migraine

2.5.4 12-Month Total Prevalent Cases of Migraine by Frequency of Episodic and Chronic

2.5.5 12-Month Total Prevalent Cases of Migraine by Type

2.5.6 12-Month Diagnosed Prevalent Cases of Migraine

2.6 Discussion

2.6.1 Epidemiological Forecast Insight

2.6.2 COVID-19 Impact

2.6.3 Limitations of the Analysis

2.6.4 Strengths of the Analysis

3 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/1q878g.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This is a syndicated feed and is brought to you in partnership with Business Wire. Health Okay Please and Trade News Network are not responsible for any claims made in this story.